organophosphonates has been researched along with 5,7-dihydroxy-6-methoxy-2-phenylchromen-4-one in 1 studies
| Studies (organophosphonates) | Trials (organophosphonates) | Recent Studies (post-2010) (organophosphonates) | Studies (5,7-dihydroxy-6-methoxy-2-phenylchromen-4-one) | Trials (5,7-dihydroxy-6-methoxy-2-phenylchromen-4-one) | Recent Studies (post-2010) (5,7-dihydroxy-6-methoxy-2-phenylchromen-4-one) |
|---|---|---|---|---|---|
| 9,968 | 880 | 3,596 | 182 | 0 | 145 |
| Protein | Taxonomy | organophosphonates (IC50) | 5,7-dihydroxy-6-methoxy-2-phenylchromen-4-one (IC50) |
|---|---|---|---|
| Receptor-type tyrosine-protein kinase FLT3 | Homo sapiens (human) | 1.48 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ho, WY; Huang, PJ; Lee, KH; Liao, JZ; Tseng, TL | 1 |
1 other study(ies) available for organophosphonates and 5,7-dihydroxy-6-methoxy-2-phenylchromen-4-one
| Article | Year |
|---|---|
Oroxylin-A and its phosphonate derivative potentiate eNOS/NO-mediated relaxation and attenuate vasoconstrictor-induced contraction in the mouse aorta.
Topics: Animals; Aorta; Endothelium, Vascular; Flavonoids; Mice; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Organophosphonates; Vasoconstrictor Agents; Vasodilation | 2022 |